Overview

Chemtai Mungo, MD, MPH, FACOG, an Assistant Professor in the UNC Department of Obstetrics and Gynecology, has been awarded a $2.5 million grant from the National Institutes of Health (NIH) to improve treatment outcomes for women living with HIV (WWH) and affected by human papillomavirus (HPV) in Africa. The five-year grant (R37CA306827) will support research focused on optimizing HPV treatment strategies in resource-limited settings. Dr. Mungo is also an Affiliate Faculty member at the Lineberger Comprehensive Cancer Center and a member of the UNC Institute for Global Health and Infectious Diseases.

The Challenge: Cervical Cancer and HIV in Africa

Cervical cancer is a leading cause of cancer-related deaths among women in sub-Saharan africa. Women living with HIV are at significantly higher risk of developing cervical cancer due to weakened immune systems and increased HPV prevalence. Effective screening and treatment programs are often hampered by limited resources, inadequate infrastructure, and a lack of trained healthcare personnel. The intersection of HIV and HPV creates a especially vulnerable population requiring tailored interventions.

According to the world Health Association, approximately 90% of cervical cancer deaths occur in low- and middle-income countries. HIV-positive women are estimated to have a six-fold increased risk of cervical cancer compared to HIV-negative women.

Dr. Mungo’s Research Focus

Dr. Mungo’s research centers on increasing access to effective, evidence-based cervical cancer prevention in low-income countries. Her work specifically investigates resource-appropriate and effective methods for treating cervical precancerous lesions. This includes exploring innovative approaches to screening, diagnosis, and treatment that can be implemented in settings with limited resources. Her research profile at UNC Global Health provides further details on her projects and publications.

Driven by her experiences witnessing preventable cervical cancer deaths in rural kenya, Dr. mungo aims to address the disparities in cervical cancer care. She emphasizes the need for solutions that are both scientifically sound and culturally sensitive.

The NIH Grant: Improving Treatment Outcomes

The $2.5 million NIH grant will enable Dr. Mungo and her team to conduct research aimed at optimizing HPV treatment protocols for WWH in Africa.The specific details of the research project were not available in the source material,but the grant’s focus suggests an examination into factors influencing treatment success,potential improvements to existing treatment methods,and strategies for enhancing adherence to treatment regimens.

The grant (R37CA306827) is highly likely to support clinical trials, data analysis, and capacity building within African healthcare systems. The ultimate goal is to reduce the burden of cervical cancer among WWH and improve their overall health outcomes.